Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.77
-0.17 (-2.86%)
At close: Feb 4, 2026, 4:00 PM EST
5.75
-0.02 (-0.35%)
After-hours: Feb 4, 2026, 5:53 PM EST

Aura Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
365411436389496-
Market Cap Growth
-5.92%-5.92%12.22%-21.59%--
Enterprise Value
221255308298631-
Last Close Price
5.758.228.8610.5016.98-
PB Ratio
2.312.701.931.993.26-
P/TBV Ratio
2.332.701.931.993.26-
Debt / Equity Ratio
0.110.120.090.110.01-
Quick Ratio
8.6010.1318.3018.0620.276.54
Current Ratio
9.0410.7718.7618.8120.906.94
Return on Equity (ROE)
-64.27%-46.01%-36.26%-33.78%-41.07%-88.60%
Return on Assets (ROA)
-35.84%-27.46%-22.18%-19.63%-24.19%-46.92%
Return on Capital Employed (ROCE)
-66.20%-57.40%-35.00%-28.20%-23.10%-114.20%
Earnings Yield
-29.16%-21.17%-17.51%-15.11%-7.11%-
FCF Yield
-24.32%-19.74%-14.79%-14.32%-6.96%-
Buyback Yield / Dilution
-15.97%-25.32%-32.34%-480.18%-1305.21%-8.54%
Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q